Current Ratio in % of Context Therapeutics Inc. from Q2 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Context Therapeutics Inc. quarterly Current Ratio history and change rate from Q2 2022 to Q3 2025.
  • Context Therapeutics Inc. Current Ratio for the quarter ending 30 Sep 2025 was 2.34K %, a 16.4% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Context Therapeutics Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 2.34K +330 +16.4% 30 Sep 2025
Q2 2025 3.15K +1.98K +168% 30 Jun 2025
Q1 2025 4.42K +3.91K +762% 31 Mar 2025
Q4 2024 3.2K +2.58K +413% 31 Dec 2024
Q3 2024 2.01K +1.2K +147% 30 Sep 2024
Q2 2024 1.17K +193 +19.7% 30 Jun 2024
Q1 2024 513 -645 -55.7% 31 Mar 2024
Q4 2023 625 -818 -56.7% 31 Dec 2023
Q3 2023 814 -765 -48.5% 30 Sep 2023
Q2 2023 981 -202 -17.1% 30 Jun 2023
Q1 2023 1.16K 31 Mar 2023
Q4 2022 1.44K 31 Dec 2022
Q3 2022 1.58K 30 Sep 2022
Q2 2022 1.18K 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.